management of egfr-mutant lung cancer with central nervous system metastases
Published 4 years ago • 797 plays • Length 1:18:11Download video MP4
Download video MP3
Similar videos
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
50:55
watch dr. leighl discuss egfr-mutated #nsclc updates from #wclc24 - https://bit.ly/24egfrlungy
-
2:06
continued use of osimertinib reduces cns metastasis in egfr mutant lung cancer
-
9:25
volumetric response of brain metastases in egfr mutant nsclc | lisa ni, md
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
52:36
making precision decisions in the treatment of nsclc with common and uncommon egfr mutations
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
17:00
brain metastases in egfr-mutant lung cancer | 2023 living with egfr-mutant lung cancer patient forum
-
14:23
treatment updates: egfr-mutant lung cancer | 2024 living with egfr-mutant lung cancer patient forum
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
41:59
testing for common and uncommon egfr mutations to guide egfr-targeted therapy in nsclc
-
2:01
dr balazs halmos: cns metastases in egfrm mnsclc
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
4:35
managing cns metastases in egfr-positive nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc